Table 1: Demographic and Clinical Characteristics - Obj_1_AF for onscoviddeath
	Total	non-use	current use

1	   70,464 (100.0)	   18,048 (100.0)	   52,416 (100.0)

Grouped age
1	      295 (0.4)	      169 (0.9)	      126 (0.2)
2	    1,375 (2.0)	      615 (3.4)	      760 (1.4)
3	    7,054 (10.0)	    2,372 (13.1)	    4,682 (8.9)
4	   21,943 (31.1)	    6,134 (34.0)	   15,809 (30.2)
5	   28,968 (41.1)	    6,233 (34.5)	   22,735 (43.4)
6	   10,829 (15.4)	    2,525 (14.0)	    8,304 (15.8)

Male
0	   16,239 (23.0)	    5,345 (29.6)	   10,894 (20.8)
1	   54,225 (77.0)	   12,703 (70.4)	   41,522 (79.2)

Grouped BMI
1	      769 (1.1)	      267 (1.5)	      502 (1.0)
2	   16,527 (23.5)	    4,701 (26.0)	   11,826 (22.6)
3	   23,921 (33.9)	    5,948 (33.0)	   17,973 (34.3)
4	   14,381 (20.4)	    3,277 (18.2)	   11,104 (21.2)
5	    6,172 (8.8)	    1,401 (7.8)	    4,771 (9.1)
6	    3,623 (5.1)	      741 (4.1)	    2,882 (5.5)
.	    5,071 (7.2)	    1,713 (9.5)	    3,358 (6.4)

Smoking status
1	   25,910 (36.8)	    6,908 (38.3)	   19,002 (36.3)
2	   38,739 (55.0)	    9,309 (51.6)	   29,430 (56.1)
3	    5,674 (8.1)	    1,780 (9.9)	    3,894 (7.4)
.	      141 (0.2)	       51 (0.3)	       90 (0.2)

Ethnicity
1	   51,123 (72.6)	   12,926 (71.6)	   38,197 (72.9)
2	      150 (0.2)	       48 (0.3)	      102 (0.2)
3	      843 (1.2)	      331 (1.8)	      512 (1.0)
4	      308 (0.4)	      125 (0.7)	      183 (0.3)
5	      309 (0.4)	       92 (0.5)	      217 (0.4)
.	   17,731 (25.2)	    4,526 (25.1)	   13,205 (25.2)

Index of Multiple Deprivation (IMD)
1	   15,082 (21.4)	    3,727 (20.7)	   11,355 (21.7)
2	   14,741 (20.9)	    3,711 (20.6)	   11,030 (21.0)
3	   14,154 (20.1)	    3,624 (20.1)	   10,530 (20.1)
4	   13,499 (19.2)	    3,548 (19.7)	    9,951 (19.0)
5	   12,988 (18.4)	    3,438 (19.0)	    9,550 (18.2)
.	        0 (0.0)	        0 (0.0)	        0 (0.0)

Diabetes Severity
1	   61,417 (87.2)	   15,413 (85.4)	   46,004 (87.8)
2	    6,051 (8.6)	    1,805 (10.0)	    4,246 (8.1)
3	    2,862 (4.1)	      768 (4.3)	    2,094 (4.0)
4	      134 (0.2)	       62 (0.3)	       72 (0.1)
.	        0 (0.0)	        0 (0.0)	        0 (0.0)

Diagnosed hypertension
1	   29,351 (41.7)	    7,500 (41.6)	   21,851 (41.7)
Heart Failure
1	    7,017 (10.0)	    1,393 (7.7)	    5,624 (10.7)
Diabetes
1	    9,047 (12.8)	    2,635 (14.6)	    6,412 (12.2)
COPD
1	    6,739 (9.6)	    1,523 (8.4)	    5,216 (10.0)
Other Respiratory Diseases
1	    2,851 (4.0)	      741 (4.1)	    2,110 (4.0)
Cancer
1	   10,709 (15.2)	    2,779 (15.4)	    7,930 (15.1)
Immunosuppressed (combination algorithm)
1	      695 (1.0)	      257 (1.4)	      438 (0.8)
Chronic kidney disease
1	   10,462 (14.8)	    2,031 (11.3)	    8,431 (16.1)
Flu vaccine
1	   50,677 (71.9)	   11,064 (61.3)	   39,613 (75.6)
Recent Oestrogen
1	      598 (0.8)	      246 (1.4)	      352 (0.7)
Recent antiplatelet
1	    6,247 (8.9)	    3,951 (21.9)	    2,296 (4.4)
Myocardial infarction
1	    2,366 (3.4)	      754 (4.2)	    1,612 (3.1)
Peripheral arterial disease
1	      633 (0.9)	      209 (1.2)	      424 (0.8)
Stroke/Transient ischaemic attack
1	    1,362 (1.9)	      333 (1.8)	    1,029 (2.0)
Venous thromboembolism
1	      866 (1.2)	      318 (1.8)	      548 (1.0)
Stroke
1	      954 (1.4)	      224 (1.2)	      730 (1.4)
Transient ischaemic attack
1	      695 (1.0)	      171 (0.9)	      524 (1.0)
Recent NSAID
1	    1,794 (2.5)	      870 (4.8)	      924 (1.8)
Recent aspirin
1	    5,159 (7.3)	    3,501 (19.4)	    1,658 (3.2)
Hazardous alcohol use
1	    8,840 (12.5)	    2,339 (13.0)	    6,501 (12.4)


GP consultation count
Median (IQR)	9 (5-15)	7 (3-12)	10 (5-16)
Min, Max	0, 202	0, 202	0, 198
Age (years)
Median (IQR)	71 (65-75)	69 (63-74)	71 (66-75)
Min, Max	18, 106	21, 106	18, 101
A&E attendance count
Median (IQR)	0 (0-1)	0 (0-0)	0 (0-1)
Min, Max	0, 54	0, 39	0, 54
Recent record of HAS-BLED score
Median (IQR)	1 (1-2)	1 (1-2)	1 (1-2)
Min, Max	0, 6	0, 6	0, 5
Ever record of HAS-BLED score in 10 years
Median (IQR)	1 (1-2)	1 (1-2)	1 (1-2)
Min, Max	0, 9	0, 9	0, 9
